Clinical Trial Update: Assess the Efficacy and Safety of Rhinocort Aqua [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 trial evaluating the efficacy and safety of Rhinocort Aqua (budesonide nasal spray) for allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Rhinocort Aqua (budesonide nasal spray)

Snippet

Sponsor: AstraZeneca | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED